Skip to main content

IRIS / MapLight: A research study of an investigational medication for adolescents and adults with Autism Spectrum Disorder (CURRENTLY RECRUITING)

Interested in participating

If you or your loved one would like to take the next step toward possible participation or if you have more questions, please contact Lily He at or 416-425-6220 ext. 6321.


Recruitment Flyer - click here to learn more (PDF)


Additional information

REB #: 3930; A randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety, and tolerability of ML-004 in adolescents and adults with autism spectrum disorders (ASD)

Learn more about this study